Clinical trial
Directly Observed Therapy for HIV Infected Adolescents
NCT00259389 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00259389 |
|---|---|
| Title | Directly Observed Therapy for HIV Infected Adolescents |
| Official title | Directly Observed Therapy (DOT) in HIV-1 Infected Adolescents |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH Pediatric AIDS Clinical Trials Group |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Behavioral |
| Interventions | Directly observed therapy (DOT) |
| Enrollment | 24 |
| Start date | Apr 1, 2006 |
| Completion | Sep 1, 2007 |
| First posted | Nov 29, 2005 |
| Last update posted | Sep 18, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: